Gliomas account for the majority of human brain tumors and the incidence of gliomas is expected to rise in upcoming years and therefore extensive efforts have been devoted to the discovery of potent antiglioma agents. Due to the importance of benzoxazoles for anticancer drug discovery, herein new benzoxazole-based hydrazone derivatives (3a-g) were designed and synthesized. The cytotoxic effects of the compounds on C6 rat glioma and NIH/3T3 mouse embryonic fibroblast cell lines were investigated using MTT assay. The apoptotic effects of the most selective anticancer agent were analyzed based on Annexin V-PI binding capacities in flow cytometry. The compounds were also investigated for their acetylcholinesterase (AChE) inhibitory effects using a modification of Ellman's spectrophotometric method. In order to evaluate the compliance of the compounds to Lipinski's rule of five, their physicochemical parameters were determined using Molinspiration software.
INTRODUCTION
Gliomas are the most common primary malignant brain tumors and the incidence of gliomas is expected to rise in upcoming years. A common approach for the treatment of glioma involves surgery, radiotherapy and chemotherapy. However, there is no 100% curative therapy available for glioma patients and survival rates related to the most malignant types of gliomas are very low. Recurrences are also frequent since conventional therapies do not take into account the unique molecular features of different subtypes of glioma [1] [2] [3] .
Efficacy of chemotherapy is limited due to poor drug delivery to the brain tumor and the correspondingly limited therapeutic response caused by partially intact blood-brain barrier (BBB) and bloodtumor barrier (BTB). Efficacy of anticancer agents is also reduced by the inherent chemoresistance of brain endothelial and glioma cells expressing the drug efflux protein, P-glycoprotein. As a result, extensive efforts have been devoted to the discovery of new antiglioma agents to improve drug delivery across the BBB/BTB and overcome drug resistance [1] [2] [3] .
Benzoxazoles represent an important class of chemical entities in medicinal chemistry as building blocks for modulating a ligand's affinity and/or selectivity towards a particular target and therefore benzoxazole scaffold is often found in ligands targeting a plethora of receptors and enzymes. Benzoxazole derivatives have been reported to show a wide range of biological activities such as antibacterial, antifungal, antiviral, anticancer, and antioxidant activities [4] [5] [6] . In particular, recent studies have indicated that benzoxazole derivatives show potent antitumor activity against different cancer cell lines [7] [8] [9] [10] [11] [12] through the inhibition of Aurora B kinase [8] , cyclooxygenase-2 (COX-2) [9, 10] , topoisomerase II [11] and the induction of Caspase-3 dependent apoptosis [12] .
Hydrazides-hydrazones have also attracted a great deal of interest as an important class of lead compounds for the development of new chemical entities to treat various diseases due to their unique structural features and diverse biological activities [13] [14] [15] . In particular, hydrazone moiety plays a pivotal role in anticancer drug development. Hydrazone derivatives have been reported to show potent antitumor activity against various cancer cell lines such as U-373 MG human glioblastoma, MCF-7 human breast adenocarcinoma, A549 human lung carcinoma, SK-OV-3 human ovary carcinoma, SK-MEL-2 human melanoma, HCT15 human colon carcinoma, MIA PaCa-2 human pancreas carcinoma, and HepG2 human hepatocellular carcinoma cell lines [14] [15] [16] [17] [18] [19] [20] .
Prompted by the aforementioned findings, herein we designed, synthesized new benzoxazole-based hydrazone derivatives and tested their in vitro cytotoxic effects on C6 rat glioma and NIH/3T3 mouse embryonic fibroblast cell lines followed by flow cytometry-based apoptosis detection in C6 cell line. The compounds were also investigated for their acetylcholinesterase (AChE) inhibitory effects. A computational study for the prediction of absorption, distribution, metabolism and excretion (ADME) properties of all compounds was performed.
RESULTS AND DISCUSSION
The synthesis of new hydrazone derivatives (3a-g) was carried out according to the steps shown in Figure 1 . In the initial step, ethyl 2-[(5-fluorobenzoxazol-2-yl)thio]acetate (1) was synthesized via the reaction of 5-fluorobenzoxazole-2-thiol with ethyl chloroacetate in the presence of potassium carbonate. The treatment of the ester (1) with hydrazine hydrate afforded the corresponding hydrazide (2) . Finally, the nucleophilic addition-elimination reaction of the hydrazide (2) with aromatic aldehydes gave the target compounds (3a-g). The structures of the compounds were confirmed by IR, 1 H NMR, 13 C NMR, mass spectral data, and elemental analysis. In the IR spectrum of compound 2, the C=O stretching vibrations gave rise to a band at 1641.42 cm -1 . The N-H stretching bands were observed in the region 3298-3203 cm -1 . The stretching bands for aromatic and aliphatic C-H groups occurred at 3111-3043 cm -1 and 2995-2939 cm -1 , respectively. N-H bending, C=N, C=C stretching bands were observed in the region 1625-1462 cm -1 . In the IR spectra of compounds 3a-g, a strong, characteristic band in the region 1687-1658 cm -1 due to the C=O stretching vibration was observed. The N-H stretching bands occurred at 3253-3184 cm -1 . The aromatic and aliphatic C-H stretching vibrations gave rise to bands at 3142-3030 cm -1 and 2980-2846 cm -1 , respectively. C=N, C=C stretching and N-H bending vibrations were observed in the region 1616-1463 cm -1 . In the IR spectrum of cyano-substituted compound 3c, the C≡N stretching band occurred at 2229.71 cm -1 .
In the 1 H NMR spectrum of compound 2, the signals due to the NH2 and NH protons of the hydrazide group appeared at 4.35 and 9.43 ppm, respectively. The signal due to the S-CH2 protons was observed at 4.08 ppm as a singlet. In the 1 H NMR spectra of compounds 3a-g, the signal due to the hydrazone proton appeared in the region 11-12 ppm as a singlet. The signals due to the S-CH2 protons were observed in the region 4.28-4.73 ppm. The signal belonging to CH=N proton appeared in the region 8.01-8.33 ppm. In the 1 H NMR spectra of compounds 3a-g, CH=N and S-CH2 protons gave rise to two singlet peaks in accordance with the presence of the E and Z isomers [21, 22] .
In the 13 C NMR spectra of all compounds, the signal due to the S-CH2 carbon was observed in the region 34-35 ppm. The signal due to the C=O carbon was observed at 165-169 ppm. In the 13 C NMR spectra of compounds 3a-g, the signal due to the hydrazone carbon was observed at 144-147 ppm. In the 13 C NMR spectrum of cyano-substituted compound 3c, the signal due to the C≡N carbon appeared at 119.10 ppm. HRMS spectral data and elemental analysis were in agreement with the proposed structures of the compounds.
MTT assay was carried out to determine the anticancer effects of the compounds on C6 rat glioma cell line (Table 1) . Biphenyl-substituted compound 3g was found to be the most potent anticancer agent against C6 cell line with an IC50 value of 4.30±0.28 µg/mL when compared with mitoxantrone (IC50= 4.56±1.24 µg/mL). This outcome indicated that biphenyl group significantly enhanced anticancer activity against C6 cell line. The increased anticancer activity can be attributed to the increased lipophilicity of the compound due to the presence of biphenyl moiety.
Toxicity to host cells is an important characteristic to assess the safety of drug candidates early in the drug discovery process. The cytotoxic effects of the compounds on NIH/3T3 mouse embryonic fibroblast cell line were investigated to evaluate whether the compounds were toxic or non-toxic to healthy cells. The selectivity index (SI) values of the compounds were also determined to compare the selectivity of the compounds ( Table 1 ). The high SI value of compound 3g pointed out that the antiglioma activity of compound 3g was selective. Due to its notable and selective antitumor effect on C6 cells, compound 3g was chosen for further studies. After 24 h incubation period, the apoptotic effects of compound 3g were analyzed based on Annexin V-PI binding capacities in flow cytometry (Table 2, Figure 2 ). Following flow cytometric analyses, the early and late apoptotic effects of compound 3g (for IC50/2 and IC50 doses) on C6 cell line were determined as 9.3% and 8.7%, respectively. According to these findings, the early apoptotic effects of this compound did not increase in a dose dependent manner, whereas the late apoptotic effects increased in a dose dependent manner. The inhibitory effects of the compounds on AChE were also determined by a modification of Ellman's spectrophotometric method (Table 3) . Galantamine was used as a positive control. According to the results, compounds 3a-g showed less AChE inhibitory activity than galantamine. Compounds 2, 3a, 3b, 3c, 3d, 3f and 3g showed less than 50% AChE inhibition at 80 µg/mL, whereas compound 3e did not show any inhibitory activity against AChE. Compound 3g was identified as the most potent AChE inhibitor (45.98±3.13%) in this series. This outcome indicated that biphenyl moiety enhanced AChE inhibitory activity. The increased activity can be attributed to its high lipophilicity due to the presence of biphenyl moiety. In order to evaluate the compliance of the compounds to Lipinski's rule of five, Molinspiration software was used to determine their physicochemical parameters (log P, TPSA, nrotb, molecular weight, number of hydrogen bond donors and acceptors, molecular volume) [23] . According to Lipinski's rule of five, most "drug like" molecules have log P ≤ 5, molecular weight ≤ 500, number of hydrogen bond acceptors ≤ 10, and number of hydrogen bond donors ≤ 5 and compounds violating more than one of these rules may have bioavailability problems [23] [24] [25] [26] . According to in silico studies, compound 3g only violated one parameter of Lipinski's rule of five, whereas other compounds did not violate Lipinski's rule (Table 4) . On the basis of Lipinski's rule of five, they were expected to have good oral bioavailability. 
CONCLUSION
In the present paper, new benzoxazole-based hydrazone derivatives were synthesized and investigated for their cytotoxic effects on C6 rat glioma, and NIH/3T3 mouse embryonic fibroblast cell lines and AChE inhibitory effects. Moreover, the compliance of the compounds to the Lipinski's rule of five was evaluated.
Biphenyl-substituted compound 3g was identified as the most promising anticancer agent against C6 cell line due to its selective and notable anticancer activity (IC50= 4.30±0.28 µg/mL) when compared with mitoxantrone (IC50= 4.56±1.24 µg/mL). The apoptotic effects of compound 3g were also investigated. This compound caused late apoptosis in a dose dependent manner. According to the in vitro and in silico studies, compound 3g stands out as a promising orally bioavailable anticancer drug candidate for further in vitro and in vivo studies. 
Chemistry
All reagents were purchased from commercial suppliers and were used without further purification. The melting points (M.p.) of the compounds were determined on a MP90 digital melting point apparatus (Mettler Toledo, Ohio, USA) and are uncorrected. IR spectra were recorded on an IRPrestige-21 Fourier Transform Infrared spectrophotometer (Shimadzu, Tokyo, Japan). 1 H NMR and 13 C NMR spectra were recorded on a Bruker spectrometer (Bruker, Billerica, MA, USA). Chemical shifts were reported in parts per million (ppm) and the coupling constants (J) were expressed in Hertz (Hz) . Mass spectra were recorded on a Shimadzu LCMS-IT-TOF system (Shimadzu, Kyoto, Japan). Elemental analyses (C, H, N) were performed on a Perkin Elmer EAL 240 elemental analyzer (Perkin-Elmer, Norwalk, CT, USA). Thin Layer Chromatography (TLC) was performed on TLC Silica gel 60 F254 aluminium sheets (Merck, Darmstadt, Germany) to check the purity of the compounds.
General procedure for the synthesis of the compounds Ethyl 2-[(5-fluorobenzoxazol-2-yl)thio]acetate (1)
A mixture of 5-fluorobenzoxazole-2-thiol (0.05 mol) and ethyl chloroacetate (0.05 mol) in the presence of potassium carbonate (0.05 mol) in acetone was refluxed for 10 h. The reaction mixture was cooled, filtered and the crude product was solved in water and then extracted with ether [22] .
2-[(5-Fluorobenzoxazol-2-yl)thio]acetohydrazide (2)
A mixture of the ester (1) (0.05 mol) and hydrazine hydrate (0.1 mol) in ethanol was stirred at room temperature for 3 h and then filtered [22] 
N'-Benzylidene-2-[(5-fluorobenzoxazol-2-yl)thio]acetohydrazide derivatives (3a-g)
A mixture of the hydrazide (2) (0.01 mol) and appropriate aldehyde (0.01 mol) was refluxed in ethanol for 6 h, filtered and crystallized from ethanol [22] . Fluorobenzoxazol-2-yl)thio]-N'-(4-fluorobenzylidene) determined in preliminary experiments). The stock solutions of the compounds were prepared in dimethyl sulfoxide (DMSO; Sigma Aldrich, Poole, UK) and further dilutions were made with fresh culture medium (the concentration of DMSO in the final culture medium was <0.1% which had no effect on the cell viability).
N'-Benzylidene-2-[(5-fluorobenzoxazol-2-yl)thio]acetohydrazide (3a)
M
2-[(5-Fluorobenzoxazol-2-yl)thio]-N'-(4-nitrobenzylidene)acetohydrazide (3b)
2-[(5-

MTT assay
The level of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (SigmaAldrich, St. Louis, MO, USA) reduction was quantified as previously described in the literature [27, 28] with small modifications [29] .
After 24 h of preincubation, the compounds and mitoxantrone (positive control) were added to give final concentration in the range 3.9-500 µg/mL and the cells were incubated for 24 h. At the end of this period, MTT was added to a final concentration of 0.5 mg/mL and the cells were incubated for 4 h at 37 °C. After the medium was removed, the formazan crystals formed by MTT metabolism were solubilized by addition of 200 µL DMSO to each well and absorbance was read at 540 nm with a microtiter plate spectrophotometer (Bio-Tek plate reader, Winooski, VT, USA). Every concentration was repeated in three wells. IC50 values were defined as the drug concentrations that reduced absorbance to 50% of control values.
Selectivity index (SI) values were calculated according to the formula [30] below:
SI= IC50 for normal cell line / IC50 for cancerous cell line
Flow cytometric analyses of apoptosis
After the cells were incubated with compound 3g and mitoxantrone at IC50/2 and IC50 concentrations, phosphatidylserine externalization, which indicates early apoptosis, was measured by FITC Annexin V apoptosis detection kit (BD Pharmingen, San Jose, CA, USA) on a BD FACSAria flow cytometer for 24 h. Annexin V staining protocol was applied according to the manufacturer's instructions (BD Pharmingen, San Jose, CA, USA). The cells were then briefly washed with cold phosphate buffer saline (PBS) and suspended in a binding buffer at a concentration of 1 × 10 6 cells/mL. Then, 100 µL of this solution containing 1 × 10 5 cells was transferred to a 5 mL test tube. After 5 µL of Annexin V and PI was added, the cells were incubated for 15 min at room temperature in the dark. Then 400 µL of 1x binding buffer was added to each tube and the cells were processed for data acquisition, and analyzed on a BD FACSAria flow cytometer using FACSDiva version 6.1.1 software (BD Biosciences, San Jose, CA, USA) [29] .
AChE inhibitory activity
The AChE inhibitory effects of the compounds were determined by Ellman's method [31] with minor modifications (Electric eel AChE was used instead of bovine AChE and buffer was added 2.4 mL instead of 3 mL) [32] . The compounds were dissolved in DMSO and tested at final concentration range from 5 to 80 μg/mL. 20 μL of AChE (1 U/mL), 10 μL sample were added to 2.4 mL buffer, and the mixture was incubated at 37 °C for 15 min. After 15 min incubation, 50 μL of 0.01 M 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB) and 20 μL of 75 mM acetylthiocholine iodide (ATCI) were added, and the final mixture was incubated at room temperature for 30 min. Blank was prepared using 10 μL of DMSO instead of the test sample, with all other procedures similar to those used in the case of the sample mixture. Absorbances were measured at 412 nm and 37 °C using polystyrene cuvettes with spectrophotometer (UV-1700, Shimadzu). Experiment was done in triplicate. Galantamine was used as a positive control. Data are expressed as mean ± standard deviation (SD). The inhibition (percent) of AChE was calculated using the following equation: I (%) = 100 − (ODsample / ODcontrol) × 100
In silico Prediction of ADME Parameters
The physicochemical parameters (log P, TPSA, nrotb, molecular weight, number of hydrogen bond donors and acceptors, molecular volume) of the compounds were calculated using Molinspiration software [23] [24] [25] [26] .
